Back to Journals » Vascular Health and Risk Management » Volume 8

The prevention and regression of atherosclerotic plaques: emerging treatments

Authors Kalanuria, Nyquist, Ling G

Received 7 May 2012

Accepted for publication 2 July 2012

Published 25 September 2012 Volume 2012:8 Pages 549—561


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Atul Ashok Kalanuria,1 Paul Nyquist,1 Geoffrey Ling1,2

1Division of Neuro Critical Care, Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, 2Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

Abstract: Occlusive vascular diseases, such as sudden coronary syndromes, stroke, and peripheral arterial disease, are a huge burden on the health care systems of developed and developing countries. Tremendous advances have been made over the last few decades in the diagnosis and treatment of atherosclerotic diseases. Intravascular ultrasound has been able to provide detailed information of plaque anatomy and has been used in several studies to assess outcomes. The presence of atherosclerosis disrupts the normal protective mechanism provided by the endothelium and this mechanism has been implicated in the pathophysiology of coronary artery disease and stroke. Efforts are being put into the prevention of atherosclerosis, which has been shown to begin in childhood. This paper reviews the pathophysiology of atherosclerosis and discusses the current options available for the prevention and reversal of plaque formation.

Keywords: cardiovascular, atherosclerotic disease, endothelium, plaque, reversal, coronary artery disease, stroke

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Serum calcium levels are not associated with coronary heart disease

Jin Y, He L, Wang Q, Chen Y, Ren X, Tang H, Song X, Ding L, Qi Q, Huang Z, Yu J, Yao Y

Vascular Health and Risk Management 2013, 9:517-520

Published Date: 3 September 2013

Rivaroxaban in atrial fibrillation

Giorgi MA, Miguel LS

Vascular Health and Risk Management 2012, 8:525-531

Published Date: 30 August 2012

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency

Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T

Vascular Health and Risk Management 2012, 8:357-361

Published Date: 5 June 2012

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion

Lichtenberg M, Käunicke M, Hailer B

Vascular Health and Risk Management 2012, 8:283-289

Published Date: 4 May 2012

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies

Christina Voulgari, Dimitrios Papadogiannis, Nicholas Tentolouris

Vascular Health and Risk Management 2010, 6:883-903

Published Date: 11 October 2010

Nitric oxide and coronary vascular endothelium adaptations in hypertension

Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al

Vascular Health and Risk Management 2009, 5:1075-1087

Published Date: 16 December 2009